NASDAQ: SIGA · Life Sciences · 2 alerts · CIK 1010086
Share price
$2.85Close, Nov 16
Market cap
$205M
Shares outstanding
71.86MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Siga Technologies Inc filings on SEC EDGAR ↗
For the nine months ended September 30, 2026, SIGA Technologies reported total revenues of $48.6 million, a significant decrease from $90.8 million in the prior year, primarily due to lower product sales. Despite the revenue decline, the company remained profitable with a net income of $6.1 million, though it experienced a net loss of $2.9 million in the third quarter of 2026.
SIGA Technologies reported financial results for the third quarter ended September 30, 2026, showing total revenues of $1.3 million and a net loss of $2.9 million. The company highlighted a new $15 million procurement contract with the Canadian Department of National Defence for oral TPOXX and the retirement of its Chief Scientific Officer, Dr. Dennis Hruby.
“While we continue to work with the U.S. Government toward a new TPOXX procurement contract, our international business remains an important part of our strategy. We recently announced a $15 million contract with the Canadian Department of National Defence, a longstanding customer, and are actively pursuing opportunities with other international governments to further diversify our customer base over time.”